Spyre Therapeutics (SYRE) Price Target Increased by 42.03% to 88.06
28/4 05:07
The average one-year price target for Spyre Therapeutics (NasdaqGS:SYRE) has been revised to $88.06 / share. This is an increase of 42.03% from the prior estimate of $62.00 dated April 12, 2026. The price target is an average of many targets provided by analys...